K Pharma,Inc. (TYO:4896)
Japan · Delayed Price · Currency is JPY 688.00
-5.00 (-0.72%)
At close: Feb 6, 2026
K Pharma,Inc. Company Description
K Pharma,Inc. engages in the research, development, manufacture, and sale of regenerative medicines and pharmaceutical products in Japan.
It develops regenerative medicine products using disease-specific induced pluripotent stem (iPS) cell technology for spinal cord injuries and cerebral infarctions.
The company was incorporated in 2016 and is headquartered in Minato, Japan.
K Pharma,Inc.
| Country | Japan |
| Founded | 2016 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 17 |
| CEO | Komei Fukushima |
Contact Details
Address: Tri-Seven Roppongi Minato, 106-0032 Japan | |
| Phone | 81 3 6629 3380 |
| Website | kpharma.co.jp |
Stock Details
| Ticker Symbol | 4896 |
| Exchange | Tokyo Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | JPY |
| ISIN Number | JP3280900006 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Komei Fukushima | Chief Executive Officer |
| Masato Matsumoto | Chief Financial Officer |